Larissa Klaase
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance.
Journal: Science immunology
Published: May 19, 2023
Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer.
Journal: Cancers
Published: September 29, 2022
Combination of PD-1/PD-L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma.
Journal: International journal of cancer
Published: May 03, 2022
Lurbinectedin shows clinical activity and immune-modulatory functions in patients with pre-treated small cell lung cancer and malignant pleural mesothelioma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 13, 2022
Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: January 25, 2022
Low-Dose JAK3 Inhibition Improves Antitumor T-Cell Immunity and Immunotherapy Efficacy.
Journal: Molecular cancer therapeutics
Published: November 22, 2021
Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 23, 2020
Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response.
Journal: EBioMedicine
Published: July 23, 2020
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model.
Journal: Journal for immunotherapy of cancer
Published: June 09, 2020
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes.
Journal: Cancer cell
Published: March 26, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026